Royalty Pharma plc (RPRX)
Largest Insider Buys in Sector
RPRX Stock Price History Chart
RPRX Stock Performance
About Royalty Pharma plc
Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic institutions, research hospitals and not-for-profits, small and mid-cap biotechnology companies, and pharmaceutical companies. Its portfolio consists of royalties on approximately 35 marketed therapies …
Insider Activity of Royalty Pharma plc
Over the last 12 months, insiders at Royalty Pharma plc have bought $0 and sold $22.16M worth of Royalty Pharma plc stock.
On average, over the past 5 years, insiders at Royalty Pharma plc have bought $38.07M and sold $167.8M worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 130,000 shares for transaction amount of $3.84M was made by Legorreta Pablo G. (CEO, Chairman of the Board) on 2023‑06‑28.
List of Insider Buy and Sell Transactions, Royalty Pharma plc
| 2024-01-04 | Sale | director | 35,702 0.0083% | $27.55 | $983,504 | +1.85% | ||
| 2024-01-03 | Sale | director | 199,098 0.0467% | $27.79 | $5.53M | +2.04% | ||
| 2024-01-02 | Sale | director | 235,200 0.0566% | $28.52 | $6.71M | +0.07% | ||
| 2023-12-29 | Sale | 10 percent owner | 65,803 0.0156% | $28.04 | $1.85M | +0.73% | ||
| 2023-12-28 | Sale | 10 percent owner | 209,863 0.05% | $28.20 | $5.92M | +1.18% | ||
| 2023-12-27 | Sale | 10 percent owner | 41,729 0.0099% | $28.01 | $1.17M | +0.96% | ||
| 2023-12-15 | Sale | 10 percent owner | 10,229 0.0024% | $28.01 | $286,499 | +3.28% | ||
| 2023-12-14 | Sale | 10 percent owner | 364,441 0.0889% | $28.91 | $10.53M | -1.26% | ||
| 2023-12-13 | Sale | 10 percent owner | 307,935 0.0753% | $28.95 | $8.92M | -3.25% | ||
| 2023-08-10 | Sale | EVP & CFO | 37,500 0.0097% | $30.75 | $1.15M | -6.43% | ||
| 2023-08-09 | Sale | EVP & CFO | 37,500 0.0097% | $30.72 | $1.15M | -6.25% | ||
| 2023-07-13 | Sale | EVP & CFO | 37,500 0.0098% | $30.93 | $1.16M | -6.47% | ||
| 2023-07-12 | Sale | EVP & CFO | 37,500 0.0098% | $31.07 | $1.17M | -8.17% | ||
| 2023-06-28 | CEO, Chairman of the Board | 130,000 0.0324% | $29.51 | $3.84M | -2.60% | |||
| 2023-06-13 | CEO, Chairman of the Board | 45,000 0.0125% | $32.78 | $1.47M | -10.40% | |||
| 2023-06-12 | CEO, Chairman of the Board | 45,000 0.0125% | $33.00 | $1.48M | -11.51% | |||
| 2023-06-06 | Sale | EVP, Investments & CLO | 79,099 0.0226% | $33.82 | $2.67M | -14.01% | ||
| 2023-06-05 | Sale | EVP, Investments & CLO | 19,215 0.0054% | $33.54 | $644,446 | -12.62% | ||
| 2023-06-02 | Sale | EVP, Investments & CLO | 93,907 0.0267% | $33.64 | $3.16M | -12.81% | ||
| 2023-05-24 | CEO, Chairman of the Board | 150,000 0.0408% | $32.25 | $4.84M | -9.04% |
Insider Historical Profitability
| RIGGS RORY B | director | 20099 0.0045% | $24.92 | 1 | 28 | <0.0001% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 10 percent owner | 38714280 8.7135% | $24.92 | 1 | 2 | <0.0001% |
| Giuliani Mario Germano | director | 7795072 1.7545% | $24.92 | 1 | 10 | <0.0001% |
| Lappe Mark | 4292136 0.966% | $24.92 | 10 | 0 | ||
| PERCEPTIVE ADVISORS LLC | 10 percent owner | 2862560 0.6443% | $24.92 | 14 | 3 |